J1813 Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units

Billable / valid for submission HCPCS Release 2026Q3

Short description: Lyumjev for insulin pump use

Version history

Release	Valid from	Valid to	Description	Billable
2026Q3	2026-07-01	current	Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units	yes

J1800 Injection, propranolol hcl, up to 1 mg
J1805 Injection, esmolol hydrochloride, 10 mg
J1806 Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
J1807 Injection, ethacrynate sodium, 1 mg
J1808 Injection, folic acid, 0.1 mg
J1809 Injection, fosdenopterin, 0.1 mg
J1811 Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
J1812 Insulin (fiasp), per 5 units
J1814 Insulin (lyumjev), per 5 units
J1815 Injection, insulin, per 5 units
J1817 Insulin for administration through dme (i.e., insulin pump) per 50 units
J1823 Injection, inebilizumab-cdon, 1 mg
J1826 Injection, interferon beta-1a, 30 mcg
J1830 Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1833 Injection, isavuconazonium, 1 mg
J1834 Injection, isoniazid, 1 mg
J1835 Injection, itraconazole, 50 mg
J1836 Injection, metronidazole, 10 mg
J1837 Injection, posaconazole, 1 mg
J1885 Injection, ketorolac tromethamine, per 15 mg